Enrique Grande

Dr. Enrique Grande, MD, PhD, MSc

Medical Oncologist | International Expert in Genitourinary & Neuroendocrine Tumors

Dr. Enrique Grande is an internationally renowned medical oncologist and one of Europe’s leading experts in bladder cancer and rare endocrine malignancies, with over 20 years of experience treating complex and advanced cancers. His clinical expertise spans genitourinary tumors—including bladder, kidney, and prostate cancers—as well as neuroendocrine and endocrine tumors such as thyroid cancer, pheochromocytomas, paragangliomas, and adrenocortical carcinoma.

A pioneer in precision oncology, Dr. Grande is known for integrating advanced molecular profiling, biomarker-driven strategies, and access to innovative therapies into highly personalized treatment plans. His approach ensures that each patient benefits from the most up-to-date scientific advances and tailored therapeutic options.

Dr. Grande currently serves as Director of the Medical Oncology Department and Director of the One Oncology Madrid Cancer Program at QuirónSalud, the largest private healthcare network in Spain. Through this flagship initiative, he leads a fully integrated, multidisciplinary oncology model that connects specialists across multiple hospitals, providing patients with seamless access to cutting-edge diagnostics, targeted therapies, and clinical trials.

He is actively involved in the global oncology community and contributes to the development of clinical guidelines and scientific programs within leading organizations such as ESMO (European Society for Medical Oncology), ASCO (American Society of Clinical Oncology), ENETS, and EAU. Dr. Grande has authored more than 300 peer-reviewed scientific publications and has played a key role as principal investigator and steering committee member in numerous international clinical trials that have helped define current standards of care—particularly in urothelial bladder cancer and neuroendocrine tumors.

Recognized worldwide for his expertise, Dr. Grande is frequently sought by international patients for second opinions and complex case evaluations. His practice combines scientific leadership with a deeply patient-centered philosophy, ensuring that individuals and their families are guided with clarity, empathy, and confidence at every stage of the cancer journey.